Skip to content

Pfizer PFE Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin73.5%-0.8pp74.3%+0.9pp73.4%+1.3pp72.1%-0.2pp72.3%+0.3pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Liquidity
Current ratio1.2×+0.1×1.2×-0.1×1.3×+0.1×1.2×-0.1×1.3×+0.1×
Leverage
Debt-to-equity0.7×-0.1×0.8×+0.1×0.7×0.0×0.7×0.0×0.7×0.0×
Per Share
Book value per share$15.72+3.9%$15.14-6.8%$16.24+4.5%$15.54-1.7%$15.82+2.2%
Valuation
Market capitalization$159.73B+12.8%$141.57B-2.3%$144.87B+4.8%$138.21B-3.8%$143.71B-4.4%
Price / sales2.5×+0.3×2.3×0.0×2.3×+0.1×2.2×-0.1×2.3×-0.1×
Price / book1.8×+0.1×1.6×+0.1×1.6×0.0×1.6×0.0×1.6×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Pfizer's ratios come from?
Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.